Abstract
An automated docking procedure was used to study binding of a series of δ-selective ligands to three models of the δ-opioid receptor. These models are thought to represent the three ligand-specific receptor conformations. Docking results are in agreement with point mutation studies and suggest that different ligands—agonists and antagonists—may bind to the same binding site under different receptor conformations. Docking to different receptor models (conformations) also suggests that by changing to a receptor-specific conformation, the receptor may open or close different binding sites to other ligands.
Similar content being viewed by others
References
Golstein A (1987) Trends Pharmacol Sci 8:456–459. doi:10.1016/0165-6147(87)90038-1
Pasternak GW (1993) Clin Neuropharmacol 16:1–18. doi:10.1097/00002826-199302000-00001
Law PY, Wong YH, Loh HH (1999) Biopolymers 51:440–455. doi:10.1002/(SICI)1097-0282(1999)51:6<440::AID-BIP6>3.0.CO;2-T
Wu S, Wong MCY, Chen M, Cho CH, Wong TM (2004) J Biomed Sci 11:726–731. doi:10.1007/BF02254356
Forster K, Kuno A, Solenkova N, Felix SB, Krieg T (2007) Am J Physiol Heart Circ Physiol 293:H1604–H1608. doi:10.1152/ajpheart.00418.2007
Quock RM, Burkey TH, Verga E, Hosohata Y, Hosohata K, Cowell S, Slate C, Ehlert FJ, Roeske WR, Yamamura HI (1999) Pharmacol Rev 51:503–532
Satoh M, Minami M (1995) Pharmacol Ther 68:343–364. doi:10.1016/0163-7258(95)02011-X
Negri L, Potenza RL, Corsi R, Melchiorri P (1991) Eur J Pharmacol 196:335–336. doi:10.1016/0014-2999(91)90450-5
Sofuoglu M, Portoghese PS, Takemori AE (1991) J Pharmacol Exp Ther 257:676
Portoghese PS, Sultana M, Nagase H, Takemori AE (1992) Eur J Pharmacol 218:195–196. doi:10.1016/0014-2999(92)90167-3
Buzas B, Izenwasser S, Portoghese PS, Cox BM (1994) Life Sci 54:PL101–PL106. doi:10.1016/0024-3205(94)00412-9
Ho BY, Holmes BB, Zhao J, Fujimoto J (1997) Eur J Pharmacol 319:109–114. doi:10.1016/S0014-2999(96)00827-8
Connor MA, Keir MJ, Henderson G (1997) Neuropharmacology 36:125–133. doi:10.1016/S0028-3908(96)00144-X
Rothman RB, Mahboubi A, Bykov V, Kim CH, deCosta BR, Jacobson AE, Rice KC (1992) Peptides 13:1137–1143. doi:10.1016/0196-9781(92)90020-4
Xu H, Partilla JS, deCosta BR, Rice KC, Rothman RB (1993) Peptides 14:893. doi:10.1016/0196-9781(93)90064-N
Kim KW, Kim SJ, Shin BS, Choi HY (2001) Life Sci 68:1649–1656. doi:10.1016/S0024-3205(01)00962-6
Xu H, Lu Y-F, Partilla JS, Pinto J, Calderon SN, Matecka D, Rice KC, Lai J, Porreca F, Anathan S, Rothman RB (1998) Peptides 19:343–350. doi:10.1016/S0196-9781(97)00294-5
Allouche S, Hasbi A, Ferey V, Sola B, Jauzac P, Polastron J (2000) Biochem Pharmacol 59:915–925. doi:10.1016/S0006-2952(99)00404-9
Cvejic S, Devi LA (1997) J Biol Chem 272:26959–26964. doi:10.1074/jbc.272.43.26959
Ni Q, Xu H, Partilla JS, Rice KC, Matecka D, Calderon SN, Porreca F, Lai J, Schmidhammer H, Krasnig R, Rothman RB (1998) Peptides 19:1079–1090. doi:10.1016/S0196-9781(98)00046-1
Cha XY, Xu H, Rice KC, Porreca F, Lai J, Ananthan S, Rothman RB (1995) Peptides 16:191–198. doi:10.1016/0196-9781(94)00182-0
Maggi CA, Schwartz TW (1997) Trends Pharmacol Sci 18:351–355
Portoghese PS (2001) J Med Chem 44:2259. doi:10.1021/jm010158+
McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Food SM (1998) Nature 393:333–339. doi:10.1038/30666
Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T, Bell GI (1993) Proc Natl Acad Sci USA 90:6736–6740. doi:10.1073/pnas.90.14.6736
Pepin M-C, Yue SY, Roberts E, Wahlestedt C, Walker P (1997) J Biol Chem 272:9260–9267. doi:10.1074/jbc.272.14.9260
Valiquette M, Vu KH, Yue SY, Wahlestedt C, Walker P (1996) J Biol Chem 271:18789–18796. doi:10.1074/jbc.271.31.18789
Li X, Varga EV, Stropova D, Zalewski T, Malatynska E, Knap RJ, Roeske WR, Yamamura HI (1996) Eur J Pharmacol 300:R1–R2. doi:10.1016/0014-2999(96)00098-2
Meng F, Ueda Y, Hoversten MT, Thompson RC, Taylor L, Watson SJ, Akil H (1996) Eur J Pharmacol 311:285–292. doi:10.1016/0014-2999(96)00431-1
Zhu J, Yin J, Law P-Y, Claude PA, Rice KC, Evans CJ, Chen C, Yu L, Liu-Chen L-Y (1996) J Biol Chem 271:1430–1434. doi:10.1074/jbc.271.3.1430
Befort K, Tabbara L, Bausch S, Chavkin C, Evans C, Keiffer B (1996) Mol Pharmacol 49:216–223
Befort K, Tabbara L, Kling D, Maigret B, Kieffer BL (1996) J Biol Chem 271:10161–10168. doi:10.1074/jbc.271.17.10161
Befort K, Zilliox C, Filliol D, Yue SY, Keiffer BL (1999) J Biol Chem 274:18574–18581. doi:10.1074/jbc.274.26.18574
Metzger TG, Paterlini MG, Ferguson DM, Portoghese PS (2001) J Med Chem 44:857–862. doi:10.1021/jm000381r
Bonner G, Meng F, Akil H (2000) Eur J Pharmacol 403:37–44. doi:10.1016/S0014-2999(00)00578-1
Kong H, Raynor K, Yasuda K, Moe ST, Portoghese PS (1993) J Biol Chem 268:23055–23058
Zhu X, Chunhe W, Cheng Z, Wu Y, Zhou D, Pei G (1997) Biochem Biophys Res Commun 232:513–516. doi:10.1006/bbrc.1997.6324
Cvejic S, Trapaidze N, Cyr C, Devi VA (1996) J Biol Chem 271:4073–4076. doi:10.1074/jbc.271.8.4073
Wang CH, Zhou DH, Chen J, Li GE, Pei G, Chi ZQ (1997) Acta Pharmacol Sin 18:337–340
Wang C, Cheng Z, Wei Q, Chen J, Li G, Pei G, Chi Z (1998) Biochem Biophys Res Commun 249:321–324. doi:10.1006/bbrc.1998.9080
Hirst RA, Smart D, Devi LA, Lambert DG (1998) J Neurochem 70:2273–2278
Meng F, Hoversten MT, Thompson RC, Taylor L, Watson SJ, Akil H (1995) J Biol Chem 270:12730–12736. doi:10.1074/jbc.270.24.14383
Jutkiewicz EM, Walker NP, Folk JE, Rice KC, Portoghese PS, Woods JH, Traynor JR (2005) J Pharmacol Exp Ther 312:1314–1320. doi:10.1124/jpet.104.078741
Knapp RJ, Landsman R, Waite S, Malatynska E, Varga E, Haq W, Hruby VJ, Roeske WR, Nagase H, Yamamura HI (1995) Eur J Pharmacol 291:129–134. doi:10.1016/0922-4106(95)90134-5
Cheturvedi K, Jiang X, Christoffers KH, Chinen N, Bandari P, Raveglia LF, Rozoni S, Dondio G, Howells RD (2000) Brain Res Mol Brain Res 80:166–176. doi:10.1016/S0169-328X(00)00134-0
Pineyro G, Archer-Lahlou E (2007) Cell Signal 19:8–19. doi:10.1016/j.cellsig.2006.05.026
Fadhil I, Schmidt R, Walpole C, Carpenter KA (2004) J Biol Chem 279:21069–21077. doi:10.1074/jbc.M311468200
Alloche S, Hasbi A, Ferey V, Sola B, Jauzac P, Polastron J (2000) Biochem Pharmacol 59:915–925. doi:10.1016/S0006-2952(99)00404-9
Salamon Z, Hruby VJ, Tollin G, Cowell S (2002) J Pept Res 60:322–328. doi:10.1034/j.1399-3011.2002.21060.x
Samama P, Cotecchia S, Costa T, Lefkowitz RJ (1993) J Biol Chem 268:4625–4636
DeLean A, Stadel JM, Lefkowitz RJ (1980) J Biol Chem 255:7108–7117
Perez DM, Karnik SS (2005) Pharmacol Rev 57:147–161. doi:10.1124/pr.57.2.2
Pogozheva ID, Lomize AL, Mosberg HI (1998) Biophys J 75:612–634 www-personal.umich.edu/∼him/modeling.htm
Decaillot FM, Befort K, Filliol D, Yue SY, Walker P, Kieffer BL (2003) Nat Struct Biol 10:629–636 www.pdb.org doi:10.1038/nsb950
Podlogar BL, Poda GI, Demeter DA, Zhang SP, Carson JR, Nielson LA, Reitz AB, Ferguson DM (2000) Drug Des Discov 17:34–50 www.opioid.umn.Edu/strumod/html
Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M (2000) Science 289:739–745. doi:10.1126/science.289.5480.739
Pogozheva ID, Lomize AL, Mosberg HI (1997) Biophys J 72:1963
Kawabata T (2003) MATRAS: a program for protein 3D structure comparison. Nucleic Acids Res 31:3367–3369. doi:10.1093/nar/gkg581
Yeagle PL, Denis C, Choi G, Alderfer JL, Albert AD (2000) Mol Vis 6:125–131
Yeagle PL, Choi G, Albert AD (2001) Biochemistry 40:11932–11937
Salom D, Lodowski DT, Stenkamp RE, Le Trong I, Golczak M, Jastrzebska B, Harris T, Ballesteros JA, Palczewski K (2006) Proc Natl Acad Sci USA 103:16123–16128. doi:10.1073/pnas.0608022103
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) J Comput Chem 19:1639–1662. doi:10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
Peng Y, Keenan SM, Zhang Q, Welsh WJ (2005) J Mol Graph Model 24:25–33. doi:10.1016/j.jmgm.2005.05.001
Hypercybe, Inc. 419 Phillip St., Waterloo, ON N2L 3X2, Canada
Kane BE, Svensson B, Ferguson DM (2006) AAPS J 8:E126–E137. doi:10.1208/aapsj080115
Kshirsagar TA, Fang X, Portoghese PS (1998) J Med Chem 41:2657–2660. doi:10.1021/jm980209b
Raynor K, Kong H, Law S, Heerding J, Tallent M, Livingston F, Hines J, Reisine T (1995) Molecular biology of opioid receptors. In: Lee TNH (ed) NIDA Research Monograph 161
Maguire PA, Loew GH (1996) Eur J Pharmacol 318:505–509. doi:10.1016/S0014-2999(96)00894-1
Portoghese PS (1993) Selective nonpeptide opioid antagonists. In: Herz A (ed) Opioids, vol I. Springer, New York
Lai J, Blisky EJ, Rothman RB, Porreca F (1994) Neuroreport 5:1049–1052
Boom DC, Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR (2002) J Pharmacol Exp Ther 303(2):723–729. doi:10.1124/jpet.102.036525
Rawls SM, Hawson JM, Inan S, Cowan A (2005) Brain Res 1049:61–69. doi:10.1016/j.brainres.2005.04.074
Saitoh A, Yoshikawa Y, Onodera K, Kamei J (2005) Psychopharmacology 182(3):327–334. doi:10.1007/s00213-005-0112-6
Farreus DL, Altenbach C, Yang K, Habbell WL, Khorana HG (1996) Science 274:768–770. doi:10.1126/science.274.5288.768
Decaillot FM, Befort K, Filliol D, Yue S, Walker P, Kieffer BL (2003) Nat Struct Biol 10:629–636. doi:10.1038/nsb950
Knapp RJ, Santoro G, DeLeon IA, Lee KB, Edsall SA, Waite S, Malatynska E, Varga E, Calderon SN, Rice KC, Rothman RB, Porreca F, Roeske WR, Yamamura HI (1996) J Pharmacol Exp Ther 277:1284–1291
Jutkiewicz EM, Eller EB, Folk JE, Rice KC, Traynor JR, Woods JH (2004) J Pharmacol Exp Ther 309:173–181. doi:10.1124/jpet.103.061242
Portoghese PS, Moe ST, Takemori AE (1993) J Med Chem 36:2572–2574. doi:10.1021/jm00069a017
Zhu J, Yin J, Law P-Y, Claude PA, Rice KC, Evans CJ, Chen C, Yu L, Liu-Chen L-Y (1996) J Biol Chem 271:1430–1434. doi:10.1074/jbc.271.3.1430
Bi-Yi C, Wen-Qiou J, Jie C, Xin-Jian C, You-Cheng Z, Zhi-Qiong C (1999) Life Sci 65:1589–1595. doi:10.1016/S0024-3205(99)00404-X
Bishop MJ, Garrido DM, Boswell GE, Collins MA, Harris PA, McNutt RW, O’Neill SJ, Wei K, Chang K-J (2003) J Med Chem 46:623–633. doi:10.1021/jm020395s
Clayson J, Jales A, Tyacke RJ, Hudson AL, Nutt DJ, Lewis JW, Husbands SM (2001) Bioorg Med Chem Lett 11:939–943. doi:10.1016/S0960-894X(01)00112-3
Calderon SN, Rice KC, Rothman RB, Porreca F, Flippen-Anderson JL, Kayakiri H, Xu H, Becketts K, Smith LE, Bilsky EJ, Davis P, Horvath R (1997) J Med Chem 40:695–704. doi:10.1021/jm960319n
Portoghese PS, Sultana M, Moe ST, Takemori AE (1994) J Med Chem 37:579–585. doi:10.1021/jm00031a006
Dondio G, Ronzoni S, Eggleston DS, Artico M, Petrillo P, Petrone G, Visenti L, Farina C, Vecchieti V, Clarke GD (1997) J Med Chem 40:3192–3198. doi:10.1021/jm9608218
Jacobson AE (1998) http://www.cpdd.vcu.edu/DEC_ARCHIVES/DEC/acrobat/ DEC 1998.pdf
Acknowledgment
This work was supported by the Ministry of Science and Environmental Protection of the Republic of Serbia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Micovic, V., Ivanovic, M.D. & Dosen-Micovic, L. Docking studies suggest ligand-specific δ-opioid receptor conformations. J Mol Model 15, 267–280 (2009). https://doi.org/10.1007/s00894-008-0396-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-008-0396-7